-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $3.2

Benzinga·04/17/2025 16:00:52
Listen to the news
Morgan Stanley analyst Erin Wright maintains PetMed Express (NASDAQ:PETS) with a Underweight and lowers the price target from $3.5 to $3.2.